Match tier
Likely match
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
K
Kiara Fairman
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: United States Food and Drug Administration (2020–2025); Alabama State University (2008–2009)
Faculty Researcher
7 h-index
15 pubs
98 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Kiara Fairman's research focuses on the application of physiologically based pharmacokinetic (PBPK) modeling across various biological contexts. Her work investigates the utility of computational models, including quantitative structure-activity relationships (QSAR), to predict physicochemical and pharmacokinetic properties of chemical compounds. Fairman has explored PBPK modeling for RNAi therapeutics, drug metabolism in specific populations, and the prediction of drug exposure in milk for lactating individuals. Her recent publications also address the application of PBPK models in forensic science and the use of New Approach Methodologies (NAMs) for life stage-specific chemical risk assessments. Fairman has published 15 papers, accumulating 93 citations, and holds an h-index of 7. She collaborates with researchers at the National Center for Toxicological Research, including Pavani Gonnabathula, Me-Kyoung Choi, and Darshan Mehta.
Metrics
- h-index: 7
- Publications: 15
- Citations: 98
Selected Publications
-
Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters (2025)
-
Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations (2025)
-
Application of Lactation Physiologically Based Pharmacokinetic Modeling to Predict Milk Exposure of Passively Diffused Drugs (2025)
-
S20-02 Maternal and maternal-fetal PBPK models for estimating therapeutic efficacy and safety in pregnancy (2024)
-
Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs) (2024)
-
Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models (2024)
-
An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science (2023)
-
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges (2021)
-
Physiologically based pharmacokinetic modeling: A promising tool for translational research and regulatory toxicology (2020)
Collaboration Network
Top Collaborators
Annie Lumen
National Center for Toxicological Research (US)
3 shared publications
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
Pavani Gonnabathula
National Center for Toxicological Research
3 shared publications
In database
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
Miao Li
National Center for Toxicological Research (US)
3 shared publications
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
Me-Kyoung Choi
National Center for Toxicological Research
2 shared publications
In database
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
Miao Li
National Center for Toxicological Research
2 shared publications
In database
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
Darshan Mehta
National Center for Toxicological Research
2 shared publications
In database
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
Miao Li
National Center for Toxicological Research (US)
1 shared publication
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
Baitang Ning
National Center for Toxicological Research
1 shared publication
In database
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
Andrew Worth
Joint Research Centre (IT)
1 shared publication
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
Alicia Paini
1 shared publication
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
Yitong Liu
Center for Food Safety and Applied Nutrition (US)
1 shared publication
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Michael S. Lawless
Simulations Plus (United States) (US)
1 shared publication
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Michelle R. Embry
Health and Environmental Sciences Institute (US)
1 shared publication
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Constance A. Mitchell
Health and Environmental Sciences Institute (US)
1 shared publication
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Shruti V. Kabadi
United States Food and Drug Administration (US)
1 shared publication
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
Similar Researchers
Based on overlapping research topics
Yanyan Qu
National Center for Toxicological Research
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Svetoslav Slavov
National Center for Toxicological Research
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Kamel Mansouri
National Center for Toxicological Research
Quantitative Structure-Activity Relationship
Pharmacological Effects and Toxicity Studies
Computer Simulation
Minjun Chen
National Center for Toxicological Research
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Zoe Li
National Center for Toxicological Research
Computational Drug Discovery Methods
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Serena Van
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Models, Animal